HANP injection 1000 clinical trials

Evaluation of hANP for prevention of acute kidney injury after cardiac surgery: A two-part randomized controlled trial with open-label extension in children aged 0–12 months.

This study is looking at a new medicine to help protect babies' kidneys after heart surgery. It aims to see if an injection can prevent kidney problems in very young children (under 1 year old) who have heart operations requiring a heart-lung machine.